Oral statins and increased bone-mineral density in postmenopausal women
- 1 June 2000
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 355 (9222), 2218-2219
- https://doi.org/10.1016/s0140-6736(00)02408-9
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroProceedings of the National Academy of Sciences, 1999
- Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.Annals Of The Rheumatic Diseases, 1996
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980